Products for Research Use Only
RegisterLogin

Sibrotuzumab

CAT: 0804-HY-P99269-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99269-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP) . Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC) [1].
CAS Number
216669-97-5
Product Name Alternative
BIBH 1; Anti-Human FAP Recombinant Antibody
UNSPSC
12352203
Target
FAP
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sibrotuzumab.html
Purity
99.05
Solubility
10 mM in DMSO
Smiles
[Sibrotuzumab]
Molecular Weight
(148.66 kDa)
References & Citations
[1]Scott AM, et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003 May;9 (5) :1639-47.|[2]Kobayashi T, et al., Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody. Mol Cancer Ther. 2024 Jul 2;23 (7) :1031-1042.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
E40YR1188Sibrotuzumab
592194Sibrotuzumab (FAP)
GTR18337993-01Sibrotuzumab Antibody
KET-10752Sibrotuzumab ELISA Kit
C00432-1mg*5Sibrotuzumab (Anti-FAP)
HC440016-01Research Grade Sibrotuzumab
E55B0605Sibrotuzumab (Reference antibody)
047668FAP (sibrotuzumab) discontinued

Popular Products